MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data

S Rana, GN Valbuena, E Curry, CL Bevan… - British journal of …, 2022 - nature.com
Background Reliable prognostic biomarkers to distinguish indolent from aggressive prostate
cancer (PCa) are lacking. Many studies investigated microRNAs (miRs) as PCa prognostic …

Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?

S Mirzaei, MDA Paskeh, Y Saghari, A Zarrabi… - International Journal of …, 2022 - Elsevier
Transforming growth factor-beta (TGF-β) is a member of a family of secreted cytokines with
vital biological functions in cells. The abnormal expression of TGF-β signaling is a common …

MicroRNAs and their influence on the ZEB family: mechanistic aspects and therapeutic applications in cancer therapy

M Ashrafizadeh, HL Ang, ER Moghadam… - Biomolecules, 2020 - mdpi.com
Molecular signaling pathways involved in cancer have been intensively studied due to their
crucial role in cancer cell growth and dissemination. Among them, zinc finger E-box binding …

[HTML][HTML] MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer

F Ghamlouche, A Yehya, Y Zeid, H Fakhereddine… - Translational …, 2023 - Elsevier
Prostate cancer (PCa) is one of the most commonly diagnosed cancers among men
worldwide. Despite the presence of accumulated clinical strategies for PCa management …

Revealing the role of miRNA-489 as a new onco-suppressor factor in different cancers based on pre-clinical and clinical evidence

MDA Paskeh, S Mirzaei, S Orouei, A Zabolian… - International Journal of …, 2021 - Elsevier
Recently, microRNAs (miRNAs) have shown to be potential therapeutic, diagnostic and
prognostic targets in disease therapy. These endogenous non-coding RNAs contribute to …

The emerging role of MicroRNAs in bone diseases and their therapeutic potential

LA Bravo Vázquez, MY Moreno Becerril… - Molecules, 2021 - mdpi.com
MicroRNAs (miRNAs) are a class of small (20–24 nucleotides), highly conserved, non-
coding RNA molecules whose main function is the post-transcriptional regulation of gene …

[HTML][HTML] Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer …

Y Dai, Z Wu, C Lang, X Zhang, S He, Q Yang, W Guo… - Theranostics, 2019 - ncbi.nlm.nih.gov
Background: The reciprocal repressive loop between ZEB1 and miRNAs has been
extensively reported to play an important role in tumor progression and metastasis of various …

RETRACTED ARTICLE: Long non-coding RNA DCST1-AS1/hsa-miR-582-5p/HMGB1 axis regulates colorectal cancer progression

L Huang, G Dai - Bioengineered, 2022 - Taylor & Francis
Statement of Retraction Long Huang, Gang Dai-2022, Long non-coding RNA DCST1-
AS1/hsa-miR-582-5p/HMGB1 axis regulates colorectal cancer progression, Bioengineered …

E2F transcription factor 2-activated DLEU2 contributes to prostate tumorigenesis by upregulating serum and glucocorticoid-induced protein kinase 1

P Li, H Xu, L Yang, M Zhan, Y Shi, C Zhang… - Cell death & …, 2022 - nature.com
Long noncoding RNAs (lncRNAs) participate in biological processes in multiple types of
tumors. However, the regulatory patterns of lncRNAs in prostate cancer remain largely …

Verbascoside inhibits the epithelial‐mesenchymal transition of prostate cancer cells through high‐mobility group box 1/receptor for advanced glycation end‐products …

CH Wu, CH Chen, PF Hsieh, YH Lee… - Environmental …, 2021 - Wiley Online Library
Introduction Prostate cancer has significant mortality and metastasis rate in the male.
Unfortunately, effective treatment for patients with advanced prostate cancer is still lacking …